Cargando…

Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment

SN38 (7-ethyl-10-hydroxy-comptothecin) is a potent metabolite of irinotecan, which has been approved for treatment of metastatic colorectal cancer. Considering the notable potency of SN38, it has been introduced as an anticancer candidate. In this study, human serum albumin (HSA) conjugates of SN38...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sepehri, Nima, Rouhani, Hasti, Ghanbarpour, Ahmad Reza, Gharghabi, Mehdi, Tavassolian, Faranak, Amini, Mohsen, Ostad, Seyed Nasser, Ghahremani, Mohammad Hossein, Dinarvand, Rassoul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033423/ https://www.ncbi.nlm.nih.gov/pubmed/24895635 http://dx.doi.org/10.1155/2014/963507

Ejemplares similares

Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) Prodrugs
por: Zhou, Mo, et al.
Publicado: (2014)

Enhanced Anti-Tumoral Activity of Methotrexate-Human Serum Albumin Conjugated Nanoparticles by Targeting with Luteinizing Hormone-Releasing Hormone (LHRH) Peptide
por: Taheri, Azade, et al.
Publicado: (2011)

Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel
por: Manoochehri, Saeed, et al.
Publicado: (2013)

Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles
por: Esfandyari-Manesh, Mehdi, et al.
Publicado: (2015)

SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma
por: Shirazi, Ali Sabouri, et al.
Publicado: (2021)

N-Terminal Domain of Fragile Histidine Triad Exerts Potent Cytotoxic Effect in HT1080 Cells and Increases Doxorubicin Cytotoxicity
por: Eslamparast, Ameneh, et al.
Publicado: (2019)

The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitro
por: Takahashi, Toshiaki, et al.
Publicado: (1997)

Use of biotin targeted methotrexate–human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy
por: Taheri, Azade, et al.
Publicado: (2011)

SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
por: Nagheh, Zahra, et al.
Publicado: (2017)

Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation
por: Yang, Wenqian, et al.
Publicado: (2019)

Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies
por: Koopaei, Mona Noori, et al.
Publicado: (2011)

Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
por: Saremi, Shahrooz, et al.
Publicado: (2013)

Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
por: Saremi, Shahrooz, et al.
Publicado: (2011)

Co-Prodrugs of 7-Ethyl-10-hydroxycamptothecin and Vorinostat with in Vitro Hydrolysis and Anticancer Effects
por: Liu, Shuangxi, et al.
Publicado: (2019)

Discovery of highly potent and selective 7-ethyl-10-hydroxycamptothecin-glucose conjugates as potential anti-colorectal cancer agents
por: Yang, Chao, et al.
Publicado: (2022)

Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
por: Hosseinzadeh, Hosniyeh, et al.
Publicado: (2012)

Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells
por: Li, Qingyong, et al.
Publicado: (2011)

Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery
por: Zu, Yuangang, et al.
Publicado: (2013)

The Time Course of JNK and P38 Activation in Cerebellar Granule Neurons Following Glucose Deprivation and BDNF Treatment
por: Vakili Zahir, Niki, et al.
Publicado: (2012)

Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
por: Dinarvand, R, et al.
Publicado: (2011)

Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes
por: Zhou, Ting, et al.
Publicado: (2020)

Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells
por: Liu, Zhen, et al.
Publicado: (2022)

Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
por: Yuan, Yue, et al.
Publicado: (2016)

Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism
por: Xing, Hua, et al.
Publicado: (2020)

Truncated forms of RUNX3 Unlike Full Length Protein Alter Cell Proliferation in a TGF-β Context Dependent Manner
por: Rahmanian, Narges, et al.
Publicado: (2017)

Synthesis and Biological Evaluation of Novel Water-Soluble Poly-(ethylene glycol)-10-hydroxycamptothecin Conjugates
por: Guo, Na, et al.
Publicado: (2015)

Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration
por: Ye, Tiantian, et al.
Publicado: (2018)

The effect of hydroxycamptothecin and pingyangmycin on human squamous cell carcinoma of the tongue
por: CHEN, PENG, et al.
Publicado: (2013)

The optimal concentration of topical hydroxycamptothecin in preventing intraarticular scar adhesion
por: Liang, Yuan, et al.
Publicado: (2014)

Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin
por: Chen, Yukun, et al.
Publicado: (2022)

Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies
por: Bao, Hanmei, et al.
Publicado: (2016)

7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth
por: Wang, Airong, et al.
Publicado: (2021)

High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast Cancer
por: Lin, Hsin-Che, et al.
Publicado: (2019)

Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect
por: Wang, Anxun, et al.
Publicado: (2008)

Carbon dots conjugated to SN38 for improved colorectal anticancer therapy
por: Mattinzoli, Deborah, et al.
Publicado: (2022)

Synthesis and Antitumor Evaluation of Biotin-SN38-Valproic Acid Conjugates
por: Dai, Yi, et al.
Publicado: (2023)

Mitochondrial-Targeted Triphenylphosphonium–Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo Investigation
por: Zhang, Kunfeng, et al.
Publicado: (2023)

Corrigendum: 7-Ethyl-10-Hydroxycamptothecin, A DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth
por: Wang, Airong, et al.
Publicado: (2021)

Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine
por: Nie, Fang, et al.
Publicado: (2015)

Hydroxycamptothecin mediates antiproliferative effects through apoptosis and autophagy in A549 cells
por: Wei, Yanjie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9dm75i2eqntnjnfvrpimd9qtl8